LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 26 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $297,084 | +1.8% | 300,000 | 0.0% | 0.13% | +10.0% |
| Q4 2022 | $291,939 | +0.7% | 300,000 | 0.0% | 0.12% | -10.4% |
| Q3 2022 | $290,000 | +1.0% | 300,000 | 0.0% | 0.13% | +20.7% |
| Q2 2022 | $287,000 | -1.4% | 300,000 | 0.0% | 0.11% | +7.8% |
| Q1 2022 | $291,000 | +117.2% | 300,000 | +122.2% | 0.10% | +110.2% |
| Q4 2021 | $134,000 | -0.7% | 135,000 | 0.0% | 0.05% | -3.9% |
| Q3 2021 | $135,000 | – | 135,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|